What are the major opportunities in the Immuno-Oncology Drugs market? What are the strategies for the Immuno-Oncology Drugs market?

For detailed insights on the major opportunities and strategies in the Immuno-Oncology Drugs market, Read More

How does the Immuno-Oncology Drugs market relate to the overall economy and other similar markets?

For detailed insights on Immuno-Oncology Drugs's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Immuno-Oncology Drugs market growth? SWOT analysis of the Immuno-Oncology Drugs market.

For detailed insights on the key dynamics influencing the Immuno-Oncology Drugs market growth and SWOT analysis of the Immuno-Oncology Drugs industry, Read More

Immuno-Oncology Drugs Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Immuno-Oncology Drugs Market Report 2026

Name: Immuno-Oncology Drugs Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Immune Checkpoint Inhibitors, Immune System Modulators, Other Monoclonal Antibodies, Cancer Vaccines, Other Types), By Therapeutic Application (Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Bladder Cancer, Other Therapeutic Application), By End-Users (Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Immuno-Oncology Drugs Market Overview

• Immuno-Oncology Drugs market size has reached to $120.37 billion in 2025

• Expected to grow to $226.31 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%

• Growth Driver: Global Surge In Cancer Cases And Its Effect On The Market

• Market Trend: Collaborative Innovations In Immuno-Oncology Advancements In Checkpoint Antibodies

• North America was the largest region in 2025.

What Is Covered Under Immuno-Oncology Drugs Market?

Immuno-oncology drugs refer to a therapy or cancer treatment that employs drugs to either boost or suppress the immune system in order to aid the body's defenses against cancer, infection, and other disorders. It makes use of chemicals produced by the body or in a lab to strengthen the immune system and assist the body in locating and eliminating cancer cells.

The main types of immuno-oncology drugs market are monoclonal antibodies, immune checkpoint inhibitors, immune system modulators, cancer vaccines, and others. Monoclonal antibodies are created by cloning a single white blood cell. Every subsequent antibody generated in this manner may be traced back to a single parent cell. The different therapeutic applications include melanoma, lung cancer, blood cancer, renal cell carcinoma, prostate cancer, bladder cancer, and others and involve various sectors such as hospitals, clinics, ambulatory surgical centers, and cancer research institutes.

Immuno-Oncology Drugs Market Global Report 2026 Market Report bar graph

What Is The Immuno-Oncology Drugs Market Size and Share 2026?

The immuno-oncology drugs market size has grown rapidly in recent years. It will grow from $120.37 billion in 2025 to $136.15 billion in 2026 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to limited availability of immuno-oncology drugs, reliance on conventional chemotherapy, increasing prevalence of cancers like melanoma and lung cancer, growing oncology-focused research initiatives, early regulatory approvals for monoclonal antibodies.

What Is The Immuno-Oncology Drugs Market Growth Forecast?

The immuno-oncology drugs market size is expected to see rapid growth in the next few years. It will grow to $226.31 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to development of bispecific antibodies and oncolytic virus therapies, expansion of personalized immunotherapy solutions, increasing investment in adoptive cell transfer therapies, rising healthcare expenditure on cancer treatment, integration of digital platforms for patient monitoring and clinical trials. Major trends in the forecast period include rising adoption of immune checkpoint inhibitors across multiple cancer types, growth in development of cancer vaccines and adoptive cell therapies, increasing focus on personalized immuno-oncology treatments, expansion of hospital and ambulatory surgical center-based immunotherapy programs, rising clinical trials and research activities in monoclonal antibodies.

Book your 30 minutes free consultation with our research experts

Global Immuno-Oncology Drugs Market Segmentation

1) By Type: Immune Checkpoint Inhibitors, Immune System Modulators, Other Monoclonal Antibodies, Cancer Vaccines, Other Types

2) By Therapeutic Application: Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Bladder Cancer, Other Therapeutic Application

3) By End-Users: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Immune Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

2) By Immune System Modulators: Cytokines, Interferons, Colony-Stimulating Factors

3) By Other Monoclonal Antibodies: Targeted Monoclonal Antibodies, Bispecific Antibodies

4) By Cancer Vaccines: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

5) By Other Types: Adoptive Cell Transfer Therapies, Oncolytic Virus Therapies

What Is The Driver Of The Immuno-Oncology Drugs Market?

The increasing incidence of cancer cases is expected to propel the growth of the immuno-oncology drugs market going forward. Cancer is a disease in which abnormal cells grow uncontrollably, potentially spreading to other parts of the body and impairing normal bodily functions. The surge in cancer cases is fueled by factors such as aging populations, lifestyle changes, and improved cancer detection methods. Immuno-oncology drugs support this shift by stimulating the body’s immune system to target and eliminate cancer cells, providing more effective and precise treatment options. For instance, in 2023, according to Cancer Australia, an Australia-based government agency, an estimated 164,694 new cancer cases were diagnosed and 51,269 deaths occurred, with prostate, breast, melanoma, colorectal, and lung cancers being the most common, while rare cancers accounted for about one-third of diagnoses and 42% of deaths. Therefore, the increasing incidence of cancer cases is driving the growth of the immuno-oncology drugs industry.

Key Players In The Global Immuno-Oncology Drugs Market

Major companies operating in the immuno-oncology drugs market are F. Hoffmann-La Roche Ltd., Merck & Co., Bristol-Myers Squibb Company, Amgen Inc, Johnson & Johnson, AstraZeneca Plc, Eli Lilly and Company, Novartis International AG, Pfizer Inc., Sanofi S.A., Arlak Biotech, Apikos Pharma, Kolaz biotech, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Takeda Pharmaceuticals, Astellas Pharma Inc, Otsuka Pharmaceutical Co Ltd, Legend Biotech Co, Zai Lab, Daiichi Pharmaceutical and Sankyo, AQVIDA GmbH, GlaxoSmithKline plc, Affimed Therapeutics, Autolus Therapeutics, Cellectis, Celyad, GammaDelta Therapeutics, Immunocore, Celon Pharma, Veropharm, Biocad, Selvita, OncoArendi Therapeutics Mabion, Fate Therapeutics, Forty-Seven, Arcus Biosciences, Gritstone Oncology, Rakuten Medical, Rubius Therapeutics, Allogene Therapeutics, Celgene Corporation, Bayer AG, Incyte Corporation, Recepta Biopharma, Sandoz Brazil, Life Pharma, Julphar, NewBridge Pharmaceuticals.

Global Immuno-Oncology Drugs Market Trends and Insights

Major companies operating in the immuno-oncology drugs market are collaborating to develop and commercialize a novel checkpoint antibody to enhance the effectiveness of cancer treatments. Strategic collaborations foster innovation through cross-disciplinary knowledge exchange, leading to the faster development of combination therapies, personalized treatments, and novel drug delivery systems. For instance, in March 2023, BioNTech SE, a Germany-based company, partnered with OncoC4 Inc, a US-based pharmaceutical company, to co-develop and commercialize a checkpoint antibody, specifically the anti-CTLA-4 monoclonal antibody candidate known as ONC-392. This partnership aims to enhance cancer treatment options across multiple solid tumor indications.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Immuno-Oncology Drugs Market?

In November 2023, AbbVie Inc., a US-based company, acquired ImmunoGen for $10.1 billion. With this acquisition, AbbVie aims to expand its portfolio by incorporating ImmunoGen's expertise in providing immuno-oncology drugs. ImmunoGen Inc. is a US-based company that offers immune checkpoint inhibitors.

Regional Insights

North America was the largest region in the immuno-oncology drugs market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Immuno-Oncology Drugs Market?

The immuno-oncology drugs market consists of sales of bevacizumab, alectinib, ibrutinib, imatinib, and palbociclib. Values in this market are ""factory gate values,"" that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Immuno-Oncology Drugs Market Report 2026?

The immuno-oncology drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the immuno-oncology drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Immuno-Oncology Drugs Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$136.15 billion
Revenue Forecast In 2035	$226.31 billion
Growth Rate	CAGR of 13.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Therapeutic Application, End-Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F. Hoffmann-La Roche Ltd., Merck & Co., Bristol-Myers Squibb Company, Amgen Inc, Johnson & Johnson, AstraZeneca Plc, Eli Lilly and Company, Novartis International AG, Pfizer Inc., Sanofi S.A., Arlak Biotech, Apikos Pharma, Kolaz biotech, CStone Pharma, C
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Immuno-Oncology Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Immuno-Oncology Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Immuno-Oncology Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Immuno-Oncology Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Immune Checkpoint Inhibitors Across Multiple Cancer Types

4.2.2 Growth In Development Of Cancer Vaccines And Adoptive Cell Therapies

4.2.3 Increasing Focus On Personalized Immuno-Oncology Treatments

4.2.4 Expansion Of Hospital And Ambulatory Surgical Center-Based Immunotherapy Programs

4.2.5 Rising Clinical Trials And Research Activities In Monoclonal Antibodies

5. Immuno-Oncology Drugs Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Ambulatory Surgical Centers

5.4 Oncology Research Centers

5.5 Specialty Cancer Treatment Centers

6. Immuno-Oncology Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Immuno-Oncology Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Immuno-Oncology Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Immuno-Oncology Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Immuno-Oncology Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Immuno-Oncology Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Immuno-Oncology Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Immuno-Oncology Drugs Market Segmentation

9.1. Global Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immune Checkpoint Inhibitors, Immune System Modulators, Monoclonal Antibodies, Cancer Vaccines, Others

9.2. Global Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Bladder Cancer, Other Therapeutic Application

9.3. Global Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Ambulatory Surgical Centers, Others

9.4. Global Immuno-Oncology Drugs Market, Sub-Segmentation Of Immune Checkpoint Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

9.5. Global Immuno-Oncology Drugs Market, Sub-Segmentation Of Immune System Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cytokines, Interferons, Colony-Stimulating Factors

9.6. Global Immuno-Oncology Drugs Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Targeted Monoclonal Antibodies, Bispecific Antibodies

9.7. Global Immuno-Oncology Drugs Market, Sub-Segmentation Of Cancer Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

9.8. Global Immuno-Oncology Drugs Market, Sub-Segmentation Of Others, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adoptive Cell Transfer Therapies, Oncolytic Virus Therapies

10. Immuno-Oncology Drugs Market Regional And Country Analysis

10.1. Global Immuno-Oncology Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Immuno-Oncology Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Immuno-Oncology Drugs Market

11.1. Asia-Pacific Immuno-Oncology Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Immuno-Oncology Drugs Market

12.1. China Immuno-Oncology Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Immuno-Oncology Drugs Market

13.1. India Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Immuno-Oncology Drugs Market

14.1. Japan Immuno-Oncology Drugs Market Overview

14.2. Japan Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Immuno-Oncology Drugs Market

15.1. Australia Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Immuno-Oncology Drugs Market

16.1. Indonesia Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Immuno-Oncology Drugs Market

17.1. South Korea Immuno-Oncology Drugs Market Overview

17.2. South Korea Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Immuno-Oncology Drugs Market

18.1. Taiwan Immuno-Oncology Drugs Market Overview

18.2. Taiwan Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Immuno-Oncology Drugs Market

19.1. South East Asia Immuno-Oncology Drugs Market Overview

19.2. South East Asia Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Immuno-Oncology Drugs Market

20.1. Western Europe Immuno-Oncology Drugs Market Overview

20.2. Western Europe Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Immuno-Oncology Drugs Market

21.1. UK Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Immuno-Oncology Drugs Market

22.1. Germany Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Immuno-Oncology Drugs Market

23.1. France Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Immuno-Oncology Drugs Market

24.1. Italy Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Immuno-Oncology Drugs Market

25.1. Spain Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Immuno-Oncology Drugs Market

26.1. Eastern Europe Immuno-Oncology Drugs Market Overview

26.2. Eastern Europe Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Immuno-Oncology Drugs Market

27.1. Russia Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Immuno-Oncology Drugs Market

28.1. North America Immuno-Oncology Drugs Market Overview

28.2. North America Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Immuno-Oncology Drugs Market

29.1. USA Immuno-Oncology Drugs Market Overview

29.2. USA Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Immuno-Oncology Drugs Market

30.1. Canada Immuno-Oncology Drugs Market Overview

30.2. Canada Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Immuno-Oncology Drugs Market

31.1. South America Immuno-Oncology Drugs Market Overview

31.2. South America Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Immuno-Oncology Drugs Market

32.1. Brazil Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Immuno-Oncology Drugs Market

33.1. Middle East Immuno-Oncology Drugs Market Overview

33.2. Middle East Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Immuno-Oncology Drugs Market

34.1. Africa Immuno-Oncology Drugs Market Overview

34.2. Africa Immuno-Oncology Drugs Market, Segmentation By Type, Segmentation By Therapeutic Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Immuno-Oncology Drugs Market Regulatory and Investment Landscape

36. Immuno-Oncology Drugs Market Competitive Landscape And Company Profiles

36.1. Immuno-Oncology Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Immuno-Oncology Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Immuno-Oncology Drugs Market Company Profiles

36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Amgen Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

37. Immuno-Oncology Drugs Market Other Major And Innovative Companies

AstraZeneca Plc, Eli Lilly and Company, Novartis International AG, Pfizer Inc., Sanofi S.A., Arlak Biotech, Apikos Pharma, Kolaz biotech, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Takeda Pharmaceuticals, Astellas Pharma Inc, Otsuka Pharmaceutical Co Ltd

38. Global Immuno-Oncology Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Immuno-Oncology Drugs Market

40. Immuno-Oncology Drugs Market High Potential Countries, Segments and Strategies

40.1 Immuno-Oncology Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Immuno-Oncology Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Immuno-Oncology Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Immuno-Oncology Drugs Market, Overview Of Key Products - Product Examples

Table 2: Global Immuno-Oncology Drugs Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Immuno-Oncology Drugs Market, Supply Chain Analysis

Table 4: Global Immuno-Oncology Drugs Market, Major Raw Material Providers

Table 5: Global Immuno-Oncology Drugs Market, Major Resource Providers

Table 6: Global Immuno-Oncology Drugs Market, Major Manufacturers (Suppliers)

Table 7: Global Immuno-Oncology Drugs Market, Major Distributors And Channel Partners

Table 8: Global Immuno-Oncology Drugs Market, Key Technologies & Future Trends

Table 9: Global Immuno-Oncology Drugs Market, Major Trends

Table 10: Global Immuno-Oncology Drugs Market, Major End Users

Table 11: Global Immuno-Oncology Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Immuno-Oncology Drugs Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Immuno-Oncology Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Immuno-Oncology Drugs Market - TAM, US$ Billion, 2025

Table 15: Global Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Immuno-Oncology Drugs Market, Sub-Segmentation Of Immune Checkpoint Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Immuno-Oncology Drugs Market, Sub-Segmentation Of Immune System Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Immuno-Oncology Drugs Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Immuno-Oncology Drugs Market, Sub-Segmentation Of Cancer Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Immuno-Oncology Drugs Market, Sub-Segmentation Of Others, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Immuno-Oncology Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Immuno-Oncology Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Immuno-Oncology Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Immuno-Oncology Drugs Market - Company Scoring Matrix

Table 99: F. Hoffmann-La Roche Ltd. Financial Performance

Table 100: Merck & Co. Financial Performance

Table 101: Bristol-Myers Squibb Company Financial Performance

Table 102: Amgen Inc Financial Performance

Table 103: Johnson & Johnson Financial Performance

Table 104: Global Immuno-Oncology Drugs Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Immuno-Oncology Drugs Market, Competitive Dashboard

Table 106: Global Immuno-Oncology Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Immuno-Oncology Drugs Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 108: Global, Immuno-Oncology Drugs Market Size Gain ($ Billion), Segmentation By Therapeutic Application, 2025 – 2030

Table 109: Global, Immuno-Oncology Drugs Market Size Gain ($ Billion), Segmentation By End-Users, 2025 – 2030

List Of Figures

Figure 1: Global Immuno-Oncology Drugs Market, Overview Of Key Products - Product Examples

Figure 2: Global Immuno-Oncology Drugs Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Immuno-Oncology Drugs Market, Supply Chain Analysis

Figure 4: Global Immuno-Oncology Drugs Market, Major Raw Material Providers

Figure 5: Global Immuno-Oncology Drugs Market, Major Resource Providers

Figure 6: Global Immuno-Oncology Drugs Market, Major Manufacturers (Suppliers)

Figure 7: Global Immuno-Oncology Drugs Market, Major Distributors And Channel Partners

Figure 8: Global Immuno-Oncology Drugs Market, Key Technologies & Future Trends

Figure 9: Global Immuno-Oncology Drugs Market, Major Trends

Figure 10: Global Immuno-Oncology Drugs Market, Major End Users

Figure 11: Global Immuno-Oncology Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Immuno-Oncology Drugs Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Immuno-Oncology Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Immuno-Oncology Drugs Market - TAM, US$ Billion, 2025

Figure 15: Global Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Immuno-Oncology Drugs Market, Sub-Segmentation Of Immune Checkpoint Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Immuno-Oncology Drugs Market, Sub-Segmentation Of Immune System Modulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Immuno-Oncology Drugs Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Immuno-Oncology Drugs Market, Sub-Segmentation Of Cancer Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Immuno-Oncology Drugs Market, Sub-Segmentation Of Others, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Immuno-Oncology Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Immuno-Oncology Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Immuno-Oncology Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Immuno-Oncology Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Immuno-Oncology Drugs Market - Company Scoring Matrix

Figure 99: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 100: Merck & Co. Financial Performance

Figure 101: Bristol-Myers Squibb Company Financial Performance

Figure 102: Amgen Inc Financial Performance

Figure 103: Johnson & Johnson Financial Performance

Figure 104: Global Immuno-Oncology Drugs Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Immuno-Oncology Drugs Market, Competitive Dashboard

Figure 106: Global Immuno-Oncology Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Immuno-Oncology Drugs Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 108: Global, Immuno-Oncology Drugs Market Size Gain ($ Billion), Segmentation By Therapeutic Application, 2025 – 2030

Figure 109: Global, Immuno-Oncology Drugs Market Size Gain ($ Billion), Segmentation By End-Users, 2025 – 2030

Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

Key Market Drivers, Trends, and Forecast for the Global Gene-Editing Transfection Chemicals Industry

Outlook for Generic Pharmaceuticals Contract Manufacturing Market: Key Developments and Future Strategies to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Veterinary Diagnostic Equipment Market Report 2026 - Global Outlook – By Product (Hematology, Immunodiagnostics, Clinical Chemistry, Molecular Testing ), By Animal (Livestock Cattle, Domestic Pets ), By End Users (Hospit...

Veterinary Laboratory Testing Services Market Report 2026 - Global Outlook – By Technology (Clinical Biochemistry, Immunodiagnostics, Hematology, Molecular Diagnostics, Other Technologies), By Animal Type (Companion Anim...

Immunochemistry Diagnostic Devices And Equipment Market Report 2026 - Global Outlook – By Product Type (Immunochemistry Analyzers, Immunochemistry Stainers, Incubators, Microscopes, Centrifuges, Autoclaves, Consumables),...

Therapeutic Proteins Market Report 2026 - Global Outlook – By Product Type (Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone ), By Function (Enzymatic And Regulatory...

Drugs for Immunotherapy Market Report 2026 - Global Outlook – By Type (Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types ), By Therapy Area (Cancer, Autoimmune & Inflammatory ...

Antibody Drug Conjugates Market Report 2026 - Global Outlook – By Type (Monoclonal Antibodies, Linker, Drug/Toxin, Other Types ), By Product Brand (Adcertis, Kadcyla, Other Product Brands), By Technology (Immunogen Techn...

Frequently Asked Questions

What is the projected market size of the Immuno-Oncology Drugs Market Report 2026 market by 2030?

The Immuno-Oncology Drugs Market Report 2026 market was valued at $120.37 billion in 2025, increased to $136.15 billion in 2026, and is projected to reach $226.31 billion by 2030. request a sample here

What is the expected CAGR for the Immuno-Oncology Drugs Market Report 2026 market during the forecast period 2025 - 2030?

The expected CAGR for the Immuno-Oncology Drugs Market Report 2026 market during the forecast period 2025–2030 is 13.5%. request a sample here

What are the key factors driving the Immuno-Oncology Drugs Market Report 2026 market?

Major growth driver of the market includes: Global Surge In Cancer Cases And Its Effect On The Market in the Immuno-Oncology Drugs Market Report 2026 market. For further insights on this market, request a sample here

Which end-use segment are covered in the Immuno-Oncology Drugs Market Report 2026 market report?

The immuno-oncology drugs market covered in this report is segmented –
1) By Type: Immune Checkpoint Inhibitors, Immune System Modulators, Other Monoclonal Antibodies, Cancer Vaccines, Other Types
2) By Therapeutic Application: Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Bladder Cancer, Other Therapeutic Application
3) By End-Users: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users Subsegments:
1) By Immune Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors
2) By Immune System Modulators: Cytokines, Interferons, Colony-Stimulating Factors
3) By Other Monoclonal Antibodies: Targeted Monoclonal Antibodies, Bispecific Antibodies
4) By Cancer Vaccines: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
5) By Other Types: Adoptive Cell Transfer Therapies, Oncolytic Virus Therapies request a sample here

What is the anticipated growth trend for the Immuno-Oncology Drugs Market Report 2026 market?

Major trend in this market includes: Collaborative Innovations In Immuno-Oncology Advancements In Checkpoint Antibodies For further insights on this market, request a sample here.

Who are the key players in the Immuno-Oncology Drugs Market Report 2026 market?

Major companies operating in the Immuno-Oncology Drugs Market Report 2026 market are Major companies operating in the immuno-oncology drugs market are F. Hoffmann-La Roche Ltd., Merck & Co., Bristol-Myers Squibb Company, Amgen Inc, Johnson & Johnson, A request a sample here.

North America was the largest region in the immuno-oncology drugs market in 2025. The regions covered in the immuno-oncology drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Book your 30 minutes free consultation with our research experts

Contact Us